Omicron specific vaccines approved for clinical trials - PM News - P.M. News

Two COVID-19 vaccine candidates developed by units of China National Biotec Group (CNBG) to target the Omicron variant approved for clinical trials

Two COVID-19 vaccine candidates developed by units of China National Biotec Group (CNBG) to target the Omicron variant were approved for clinical trials as boosters in Hong Kong, the Sinopharm subsid… [+1078 chars]

full article...